Polynovo (ASX:PNV) share price rises despite widening losses

The Polynovo Ltd (ASX:PNV) share price is rising slightly today, despite the company reporting a loss for the first half of FY2021.

| More on:
A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Polynovo Ltd (ASX: PNV) shares are swinging around today after the company released its earnings report for the first half of the 2021 financial year (1H21) before market open this morning. At the time of writing, the Polynovo share price has risen 0.83% to $2.43 after climbing as high as $2.47 earlier in the day.

What did Polynovo report this morning?

Polynovo is an ASX health care company that specialises in treatments for burn injuries and other skin maladies.

The Polynovo share price is staying afloat today after the biotech reported that revenues for 1H21 came in at $12.8 million, up 25.3% over the $10.2 million from the prior corresponding period (1H20). Gross margins for product sales rose 3.9% as well.

However, that was offset by expenses increasing 32.6% from $11.2 million in 1H20 to $13 million in 1H21. A large component of this increase came from increased staff headcount.

That rise in expenses helped push earnings before interest, tax, depreciation and amortisation (EBITDA) to a loss of $2.9 million, up 46.2% from the previous loss of $1 million. Earnings before interest and tax (EBIT) losses also rose 41%, going from a loss of $2.4 million in 1H20 to a loss of $3.3 million in 1H21.

That resulted in Polynovo delivering a net profit after tax loss of $3.54 million, up 46.3% from the $2.42 million loss of 1H20.

Overall, the company posted an underlying loss of $0.87 million for 1H21, down 40.2% from its loss of $1.45 million in 1H20. No dividend was announced, in case you were wondering.

Polynovo has blamed the coronavirus pandemic on "lumpy" revenues for the period, citing "reduced access and reduced elective surgery in all regions".

Even so, the company has pointed to a 31.2% rise in sales of its flagship NovoSorb product as a bright spot over the period. It also highlighted the fact it managed to sign 22 additional customers in the United States, which brings the total new accounts opened for the 2020 calendar year to 109. That's an 89% rise over the 2019 calendar year.

About the Polynovo share price

Although the Polynovo share price is having a decent day today, the company has had a rough start to the year. Polynovo shares remain down 37.15% year to date, and down more than 14% over the past 12 months. In saying that, Polynovo shares are still up more than 1,170% since August 2017.

On the current Poynovo share price, the company has a market capitalisation of around $1.61 billion.

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Morgans says these are some of the very best ASX 200 shares to buy

The broker believes these shares could be destined to deliver big returns.

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Energy Shares

1 ASX penny stock I'd buy now while it's only 5 cents

I think this ASX penny stock has outsized growth potential.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Broker Notes

Where to invest $8,000 on the ASX in April 2024

A leading broker thinks these shares would be quality options this month.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Chalice Mining, Cleanaway, Kogan, and Perpetual shares are sinking today

These ASX shares are having a tough time on Wednesday. But why?

Read more »

Man looking at his grocery receipt, symbolising inflation.
Share Market News

Why the ASX 200 just crumbled on today's inflation print

ASX 200 investors are hitting the sell button following the latest Australian inflation news.

Read more »